Literature DB >> 26874804

Bile acids in drug induced liver injury: Key players and surrogate markers.

Heiko S Schadt1, Armin Wolf1, Francois Pognan1, Salah-Dine Chibout1, Michael Merz1, Gerd A Kullak-Ublick2.   

Abstract

Bile acid research has gained great momentum since the role of bile acids as key signaling molecules in the enterohepatic circulation was discovered. Their physiological function in regulating their own homeostasis, as well as energy and lipid metabolism make them interesting targets for the pharmaceutical industry in the context of diseases such as bile acid induced diarrhea, bile acid induced cholestasis or nonalcoholic steatohepatitis. Changes in bile acid homeostasis are also linked to various types of drug-induced liver injury (DILI). However, the key question whether bile acids are surrogate markers for monitoring DILI or key pathogenic players in the onset and progression of DILI is under intense investigation. The purpose of this review is to summarize the different facets of bile acids in the context of normal physiology, hereditary defects of bile acid transport and DILI.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26874804     DOI: 10.1016/j.clinre.2015.12.017

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  26 in total

1.  Quantification of common and planar bile acids in tissues and cultured cells.

Authors:  Stephanie J Shiffka; Jace W Jones; Linhao Li; Ann M Farese; Thomas J MacVittie; Hongbing Wang; Peter W Swaan; Maureen A Kane
Journal:  J Lipid Res       Date:  2020-07-22       Impact factor: 5.922

Review 2.  Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.

Authors:  M Mosedale; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2017-01-11       Impact factor: 6.875

3.  Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in Collaborative Cross mice.

Authors:  Merrie Mosedale; Yanwei Cai; J Scott Eaddy; Patrick J Kirby; Francis S Wolenski; Yvonne Dragan; William Valdar
Journal:  Toxicology       Date:  2021-08-18       Impact factor: 4.571

4.  Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.

Authors:  Izna Ali; Seher Khalid; Bruno Stieger; Kim L R Brouwer
Journal:  Mol Pharm       Date:  2019-01-25       Impact factor: 4.939

5.  Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.

Authors:  James J Beaudoin; Jacqueline Bezençon; Noora Sjöstedt; John K Fallon; Kim L R Brouwer
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

6.  Identification of Candidate Risk Factor Genes for Human Idelalisib Toxicity Using a Collaborative Cross Approach.

Authors:  Merrie Mosedale; Yanwei Cai; John Scott Eaddy; Robert W Corty; Manisha Nautiyal; Paul B Watkins; William Valdar
Journal:  Toxicol Sci       Date:  2019-12-01       Impact factor: 4.849

7.  Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.

Authors:  Brandy Garzel; Tao Hu; Linhao Li; Yuanfu Lu; Scott Heyward; James Polli; Lei Zhang; Shiew-Mei Huang; Jean-Pierre Raufman; Hongbing Wang
Journal:  Pharm Res       Date:  2020-01-06       Impact factor: 4.200

8.  Poria Attenuates Idiosyncratic Liver Injury Induced by Polygoni Multiflori Radix Praeparata.

Authors:  Dan Gao; Jing-Yao Pang; Cong-En Zhang; Chun-Yu Li; Can Tu; Hai-Zhu Zhang; Ming Niu; Yin Xiong; Xiao-He Xiao; Kui-Jun Zhao; Wei-Wei Gao; Jia-Bo Wang
Journal:  Front Pharmacol       Date:  2016-10-18       Impact factor: 5.810

9.  Clinical Characteristics of Patients with Drug-induced Liver Injury.

Authors:  Li-Xia Yang; Cheng-Yuan Liu; Lun-Li Zhang; Ling-Ling Lai; Ming Fang; Chong Zhang
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

10.  Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model.

Authors:  Xuan Ni; Yimeng Gao; Zhitao Wu; Leilei Ma; Chen Chen; Le Wang; Yunfei Lin; Lijian Hui; Guoyu Pan
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.